Growth Metrics

Celularity (CELU) Equity Ratio (2020 - 2025)

Celularity (CELU) has disclosed Equity Ratio for 6 consecutive years, with 0.18 as the latest value for Q3 2025.

  • On a quarterly basis, Equity Ratio fell 231.15% to 0.18 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.18, a 231.15% decrease, with the full-year FY2024 number at 0.07, down 76.6% from a year prior.
  • Equity Ratio was 0.18 for Q3 2025 at Celularity, up from 0.21 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.5 in Q4 2022 to a low of 5.05 in Q2 2021.
  • A 5-year average of 0.19 and a median of 0.21 in 2022 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: soared 119.47% in 2021, then crashed 231.15% in 2025.
  • Celularity's Equity Ratio stood at 0.24 in 2021, then surged by 106.58% to 0.5 in 2022, then plummeted by 42.6% to 0.28 in 2023, then crashed by 76.6% to 0.07 in 2024, then plummeted by 364.09% to 0.18 in 2025.
  • Per Business Quant, the three most recent readings for CELU's Equity Ratio are 0.18 (Q3 2025), 0.21 (Q2 2025), and 0.04 (Q1 2025).